Endocrine effects of IL-1 alpha and beta administered in a phase I trial to patients with advanced cancer.
Curti BD, Urba WJ, Longo DL, Janik JE, Sharfman WH, Miller LL, Cizza G, Shimizu M, Oppenheim JJ, Alvord WG, Smith JW 2nd.
Curti BD, et al. Among authors: urba wj.
J Immunother Emphasis Tumor Immunol. 1996 Mar;19(2):142-8. doi: 10.1097/00002371-199603000-00007.
J Immunother Emphasis Tumor Immunol. 1996.
PMID: 8732697
Clinical Trial.